Pre-conference Session
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 0
Additional fee session. Held in conjunction with the AGS Annual Meeting
We are pleased to announce the in-person annual meeting of the US Deprescribing Research Network - open to all people who are conducting or care about research on deprescribing medications and addressing medication overuse among older adults.
This meeting will comprise a wide-ranging series of sessions and activities that are focused on:
- Enhancing skills, providing multidisciplinary perspectives, and offering practical guidance on and opportunities for deprescribing research
- Communicating how the network can help you and your research interests
- Building collaborations and community among people interested in deprescribing research and how it can be used to improve care for older adults
The meeting speakers and agenda are not yet finalized, but please see our website for examples of agendas from the last several years of meetings. The meeting will include a poster session. Encore submissions from research submitted for presentation at AGS and other meetings are welcome. Click here to submit an abstract.
Join us as we build a community of researchers and stakeholders that will generate science, address logistical and safety challenges, and develop infrastructure to promote the conduct and dissemination of research on deprescribing.
7:45-8:30 AM | Registration and Breakfast |
8:30-9:00 AM | Welcome Address |
9:00-10:00 AM | Keynote Address: Topic TBD Emily Reeve, BPharm(Hons), PhD – Monash University |
10:00-10:15 AM | Break (with morning snacks) |
10:15-11:15 AM | Moderated Panel: Deprescribing and Age-Friendly Health Systems |
11:15AM – 12:00PM | Updates in Deprescribing Research |
12:00 AM-12:45 PM | Lunch Break |
12:45-1:45 PM | USDeN-Sponsored Research - presentations with panel discussion |
1:45-2:45 PM | Breakout Groups – small group discussion based on attendee interest |
2:45-4:00 PM | Poster Session (with afternoon snacks) |
4:00-4:45 PM | Moderated Panel: Negative Deprescribing Trials – Implications for the Field and Future Intervention Studies |
4:45-5:00 PM | Closing Remarks |